← Leaderboards
Shiuh-Wen Luoh
Portland Va Medical Center
$0
Attributed
$0
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2015–25$1$1$1$0$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 3
By mechanism
I01$0 · 3
Top collaborators
- Cynthia Ann Brandt5 shared
- Sally Haskell5 shared
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmWomanMilitary PersonnelMalignant NeoplasmsGenesScreeningIncidenceGeneticPhenotypeBreast Cancer Risk FactorMammographyBreast DensityBasePathway InteractionsAffectInnovationAreaErbb2 GeneBreast Cancer DetectionBreast Cancer CellAnimal ModelGrb7 GeneEarly DiagnosisPrograms
Grant awards (13)
A Mouse Model of Persistence of Ductal and Alveolar Hyperplasia and Breast Cancer$0
I01 · FY2025 · VA · contact PI
A Mouse Model of Persistence of Ductal and Alveolar Hyperplasia and Breast Cancer$0
I01 · FY2025 · VA · contact PI
Predicting the Breast Cancer Risk for Women Veterans$0
I01 · FY2023 · VA · contact PI
Predicting the Breast Cancer Risk for Women Veterans$0
I01 · FY2023 · VA · contact PI
Predicting the Breast Cancer Risk for Women Veterans$0
I01 · FY2023 · VA · contact PI
Predicting the Breast Cancer Risk for Women Veterans$0
I01 · FY2020 · VA · contact PI
Targeting GRB7 Signaling in Solid Tumors$0
I01 · FY2020 · VA · contact PI
Targeting GRB7 Signaling in Solid Tumors$0
I01 · FY2020 · VA · contact PI
Predicting the Breast Cancer Risk for Women Veterans$0
I01 · FY2019 · VA · contact PI
Targeting GRB7 Signaling in Solid Tumors$0
I01 · FY2018 · VA · contact PI
Targeting GRB7 Signaling in Solid Tumors$0
I01 · FY2017 · VA · contact PI
Targeting GRB7 Signaling in Solid Tumors$0
I01 · FY2016 · VA · contact PI
Targeting GRB7 Signaling in Solid Tumors$0
I01 · FY2015 · VA · contact PI